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A B S T R A C T
Ischemic stroke is characterised by a lack of oxygen and glucose in the brain, leading 
to excessive glutamate release and neuronal cell death. Adenosine is produced in 
response to ATP depletion and acts as an endogenous neuromodulator that reduces 
excitotoxicity. Persea major (Meins.) L.E. Kopp (Lauraceae) is a medical plant that 
is indigenous to South Brazil, and the rural population has used it medicinally due 
to its anti-inflammatory properties. The aim of this study was to evaluate the 
neuroprotective effect of Persea major methanolic extract against oxygen and glucose 
deprivation and re-oxygenation as well as to determine its underlying mechanism 
of action in hippocampal brain slices. Persea major methanolic extract (0.5 mg/ml) 
has a neuroprotective effect on hippocampal slices when added before or during 
15 min of oxygen and glucose deprivation or 2 h of re-oxygenation. Hippocampal slices 
subjected to oxygen and glucose deprivation and re-oxygenation showed significantly 
reduced glutamate uptake, and the addition of Persea major methanolic extract in the 
re-oxygenation period counteracted the reduction of glutamate uptake. The presence of 
A1 or A2A, but not A2B or A3 receptor antagonists, abolished the neuroprotective effect of 
Persea major methanolic extract. In conclusion, the neuroprotective effect of Persea major 
methanolic extract involves augmentation of glutamate uptake and modulation of A1 
and A2B adenosine receptors. 
© 2013 Elsevier Editora Ltda. 
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Introduction
Persea major (Meins.) L.E. Kopp, Lauraceae, is a medical plant 
that is grown mainly in South Brazil. It is popularly known 
as “pau-andrade”, “abacate-do-mato” or “canela-rosa”, 
and the rural population has used it to treat skin wounds, 
inflammation and gastric disorders. Previous studies 
demonstrated that the methanolic extract obtained from 
the bark of Persea major displays antibacterial (Schlemper 
et al., 2001) and antispasmodic (Cechinel-Filho et al., 2007) 
effects. Gastroprotective and intestinal motility inhibitory 
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effects were also observed with the hydroalcoholic extract of 
Persea major (Cosmo et al., 2007). 
Ischemic stroke is caused by a transient or permanent 
reduction of blood flow to the brain, which leads to a complex 
cascade of events that culminate in neuronal death (Hofmeijer 
and van Putten, 2012). Ischemic stroke represents the main 
cause of long-lasting disabilities, and it is the third leading 
cause of death in major industrialised countries (Savitz and 
Mattle, 2013). Oxygen and glucose deprivation (OGD) in brain 
tissue preparations is often used as an in vitro model of cerebral 
ischemia (Arias et al., 1999; Brongholi et al., 2006; Matsuda 
et al., 1992; Oliveira et al., 2002) that allows for the evaluation 
of neural degeneration. Additionally, this model system allows 
for the study of the effects of putative protective compounds in 
a cerebral structure that is especially susceptible to ischemic 
insult in a tissue preparation that maintains the cellular 
architecture observed in situ (Dal-Cim et al., 2011).
During OGD, the lack of glucose and oxygen reduces ATP 
levels, which leads to the collapse of the Na+/K+ electrochemical 
gradient. After OGD, when oxygen levels are normalised, 
termed the re-oxygenation period, ischemic insult can be 
aggravated by the additional generation of reactive oxygen 
species, mostly in the mitochondrial electron transport chain, 
inflammation and the abnormal release of neurotransmitters 
(Kostandy, 2012). As a result, glutamate transporters operate 
in a reverse direction, releasing excessive glutamate (Danbolt, 
2001), resulting in the overstimulation of the NMDA receptor 
(excitotoxicity) (Lai et al., 2010). 
Adenosine is an endogenous compound that modulates 
neurotransmission. The intracellular concentration of adenosine 
is tightly linked to the energy charge of cells, as small decreases 
in the energy charge result in large increases in the intracellular 
levels of adenosine (Cunha, 2001), which can be released to the 
extracellular space by adenosine transporters. Extracellular 
adenosine then acts on metabotropic adenosine receptors located 
in the cell membrane, A1, A2A, A2B and A3 receptors. In the nervous 
system, adenosine exerts a wide range of effects (Fredholm, 2007; 
Fredholm et al., 2005), but it generally inhibits the pre-synaptic 
activity of glutamatergic transmission (Dolphin and Archer, 
1983); thus, adenosine plays an important protective role against 
excitotoxic/ischemic damage in the brain (Lopes et al., 2011). 
Despite extensive and continued research on the 
mechanisms of ischemia-induced cell death, there are currently 
no pharmacological interventions that provide significant 
neuroprotection against brain ischemia or injury in the clinical 
setting. Because inflammation is a key event in ischemic brain 
injury (Xia et al., 2010) and Persea major has anti-inflammatory 
activities (Cosmo et al., 2007), we evaluated the neuroprotective 
effect of the Persea major methanolic extract (PMME) against 
OGD-induced cell damage and sought to unravel its underlying 
mechanism of action in hippocampal brain slices. 
Materials and Methods
Plant material
Persea major (Meins.) L.E. Kopp, Lauraceae, bark was collected in 
Canoinhas, Santa Catarina, Brazil, in 2010. The plant material 
was identified by M. L. Brotto, and a specimen voucher (number 
290857) of the plant was deposited in the Municipal Botanical 
Museum of Curitiba, Brazil.
Extract preparation
Methanolic extract was obtained by successive percolation 
of dried and powdered Persea major bark (3 kg) with 
methanol for 21 days. The solvent was changed every seven 
days, in the dark, at room temperature. The extract was 
evaporated in vacuo, and the residue was powdered and 
maintained at -20 °C until use.
Drugs
[3H]Glutamate was purchase from Amersham Life Science. 
All other reagents were obtained from Sigma (St. Louis, MO, 
USA). The selective adenosine A1 receptor selective antagonist 
8-cyclopentyl-1,3-dipropylxanthine (DPCPX) and the selective 
adenosine A2A receptor antagonist 4-(-2-[7-amino-2-{2-furyl}
{1,2,4}triazolo{2,3-a} {1,3,5}triazin-5-yl-amino]ethyl)phenol 
(ZM241385) were dissolved and added to the hippocampal 
brain slices at a final concentration of 0,01% dimethylsulfoxide 
(DMSO). The selective A3 adenosine receptor antagonist 
N-(2-methoxyphenyl)-N’-[2-(3-pyridinyl)-4-quinazolinyl]-urea 
(VUF5574, 1 μM) was also prepared in DMSO and added to 
slices at a final concentration of 1% DMSO. The antagonists 
were diluted in physiological buffer to the indicated final 
concentrations: 100 nM DPCPX (Molz et al., 2009); 50 nM 
ZM241385 (Molz et al., 2009); 0,1 μM alloxazine (Brown and 
Dale, 2000) and 1 μM VUF5574 (Stella et al., 2003). 
Animals
Male Swiss mice (60-90 days old, weighing 20-30 g) were 
obtained from our local breeding colony and maintained on a 
12-h light-12 h dark schedule at 25º C with food and water ad 
libitum. All experiments followed the “Principles of laboratory 
animal care” (NIH publication No. 85-23, revised 1985) and were 
approved by the local Ethical Committee of Animal Research 
(CEP/UnC 087/2010).
Preparation and incubation of hippocampal slices 
Mice were sacrificed by decapitation, and the hippocampi 
were rapidly removed and placed in ice-cold Krebs-Ringer 
bicarbonate buffer (KRB; 122 mM NaCl, 3 mM KCl, 1.2 mM 
MgSO4, 1.3 mM CaCl2, 0.4 mM KH2PO4, 25 mM NaHCO3 and 10 
mM D-glucose). The buffer was bubbled with 95% O2-5% CO2 
at pH 7.4. Slices (0.4 mm thick) were rapidly prepared using a 
McIlwain Tissue Chopper, separated in KRB at 4 °C and allowed 
to recover for 30 min in KRB at 37 °C for stabilisation (Oliveira 
et al., 2002). 
In the OGD model, hippocampal slices were incubated in 
a modified KRB buffer, where D-glucose was replaced with 10 
mM 2-deoxyglucose (Pocock and Nicholls, 1998), and bubbled 
with nitrogen throughout the incubation period (Strasser and 
Fischer, 1995). During the re-oxygenation period, the OGD 
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buffer was replaced by physiological KRB and bubbled with 
95% O2–5% CO2. 
Treatment of hippocampal slices 
To determine whether PMME was toxic to hippocampal slices, 
PMME was dissolved in aqueous buffers (KRB) and added to 
slices for 2 h and 15 min. 
To verify the neuroprotective effect of PMME, the slices were 
treated as follows: (a) slices were pre-incubated with PMME 
for 15 min and then subjected to OGD and re-oxygenation; 
(b) PMME was added to slices only during the OGD period and 
then subjected to re-oxygenation; or (c) slices were subjected 
to OGD and then PMME was added during the re-oxygenation 
period (Oleskovicz et al., 2008). In all experiments, the slices 
were incubated for 2 h and 15 min in physiological buffer (KRB) 
alone as a control. In experiments where adenosine receptors 
antagonists were tested, hippocampal slices were treated with 
adenosine antagonists for 15 min before adding PMME, and the 
antagonists were present the during re-oxygenation period. 
The following antagonists were used: selective adenosine 
A1 receptor antagonist (DPCPX, 100 nM), adenosine A2A 
receptor antagonist (ZM241385, 50 nM), adenosine receptor 
A2B antagonist (alloxazine, 0,1 μM) and adenosine A3 receptor 
antagonist (VUF5574, 1 μM). 
To assess the involvement of glutamate transport in the 
neuroprotective effect of PMME, the extract was dissolved in 
HBSS. Hippocampal brain slices were subjected to OGD, and 
PMME was added during the re-oxygenation period.
Cellular viability assay
Cell viability was determined by measuring the ability of cells to 
reduce MTT (3-(4,5-dimethylthiazol-2-yl-diphenyltetrazolium 
bromide; Sigma) (Mosmann, 1983). Hippocampal slices were 
incubated with MTT (0.5 mg/ml) in KRB for 30 min at 37 ºC. The 
tetrazolium ring of MTT is cleaved by active dehydrogenases 
and produces precipitated formazan. Next, 200 μl DMSO 
was used to dissolve the formazan, generating a coloured 
compound. The optical density of each well was measured 
using a microplate reader (Labsystems Multiskan MS-550 nm).
Glutamate uptake assay
L-[3H]-glutamate uptake was evaluated as previously described 
(Molz et al., 2009). After OGD and re-oxygenation, hippocampal 
slices were maintained for 15 min at 37 °C in HBSS containing 
the following (mM): 1.3 CaCl2, 137 NaCl, 5 KCl, 0.65 MgSO4, 
0.3 Na2HPO4, 1.1 KH2PO4, 2 glucose and 5 HEPES. Uptake was 
assessed by adding 0.33 μCi/ml L-[3H]-glutamate with 100 μM 
of unlabelled glutamate. After 7 min, incubation was stopped 
by discarding the incubation medium, and the slices were 
subjected to two ice-cold washes with 1 ml HBSS. The slices 
were solubilised by overnight incubation in 0.1% NaOH/0.01% 
SDS. Aliquots of the resulting slice lysates were collected to 
determine the intracellular L-[3H]-glutamate content of using 
a scintillation counter. Sodium-independent uptake was 
determined using choline chloride instead of sodium chloride 
in the HBSS buffer. Non-specific sodium-independent uptake 
(approximately 30% of total glutamate uptake) was subtracted 
from the total uptake to obtain the specific sodium-dependent 
glutamate uptake. The results are expressed as nmol of 
L-[3H]-glutamate taken up per mg of protein per min. Protein 
content was determined according to Peterson (1977), using 
bovine albumin as a standard.
Statistical analysis
The results are expressed as the means ± standard error of 
mean (SEM). Comparisons among groups were performed by 
one-way analysis of variance (ANOVA) followed by Tukey’s 
test (Graphpad Prism), and p ≤ 0.05 was considered to be 
statistically significant.
Results and discussion
The viability of hippocampal slices incubated in control 
conditions with increasing concentrations of PMME is shown in 
Fig. 1. No significant changes on cellular viability were observed 
at any concentration tested. The results are expressed as the 
percentage viability with respect to the control group (100%).
Considering that the extract was not toxic to hippocampal 
slices, they were pre-incubated in KRB buffer for 15 min with 
increasing concentrations of PMME (0.5 to 500 μg/ml) and 
then subjected to OGD and re-oxygenation (OGD+R). Ischemic 
conditions (OGD+R) significantly decreased cellular viability 
(p ≤ 0.001) (Fig. 2). Pretreatment with PMME extract (5 μg/ml) 
significantly inhibited OGD+R induced cell death (p ≤ 0.001) 
to a similar extent as MK-801 (50 μM), an NMDA receptor 
antagonist. Based on this result, this PMME concentration was 
used in all subsequent experiments.
Next, PMME extract was added to slices during 15 min of 
OGD or during the 2 h re-oxygenation period. PMME treatment 
significantly reduced cell death in OGD or OGD+R-induced 
hippocampal slices (Fig. 3). Therefore, not only is PMME 
Fig. 1 - Effect of crescent concentrations of PMME on 
cellular viability of hippocampal slices incubated in control 
conditions. Slices were incubated for 2 h and 15 min in 
KRB (100% of cellular viability, dashed lines) or in KRB with 
crescent concentrations of PMME (0.5, 1, 5, 10, 50 100 and 
500 μg/ml). These results represent the means ± SEM of 
five experiments carried out in triplicate. There was no 
significant difference between the groups.
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Fig. 3 - Effect of PMME on oxygen/glucose deprivation and re-
oxygenation (OGD+R)-induced cell death. PMME (5 μg/ml) was 
incubated during the 15 min OGD time period or during the 2 
h re-oxygenation (R) period. The control group (dashed lines) 
was considered to be 100%. The results represent the means 
± SEM of five experiments carried out in triplicate. * Indicates 
that the mean is significantly different from all other groups; 
p ≤ 0.05; F = 7.292 (ANOVA followed by Tukey’s test).
neuroprotective as a pretreatment but, more importantly, 
it can also reverse cellular injury when it is already been 
activated. This experiment was performed in a condition that 
is clinically relevant to the treatment of ischemic injury. 
Impairment of glutamate transport and excessive activation 
of glutamate receptors are involved in ischemia-induced 
damage in vitro and in vivo (Dal-Cim et al., 2011; Puyal et al., 
2013). Because MK-801, an NMDA subtype receptor antagonist, 
afforded the same level of neuroprotection as PMME extract 
Fig. 2 - Effect of preincubation with crescent concentrations of 
PMME (0.5, 1, 5, 10, 50, 100 and 500 μg/ml)  on cellular viability 
reduction induced by oxygen/glucose deprivation and re-
oxygenation (OGD+R). The control group (dashed lines) was 
considered to be 100%. The results represent the means±SEM 
of five experiments carried out in triplicate.  
*** (p ≤ 0.001), ** (p ≤ 0.01) and * (p ≤ 0.05) indicate that the 
mean is significantly different from the control (dashed lines), 
PMME 5 μg/ml or MK-801 groups; ### (p ≤ 0.001; F = 8.809) 
indicates that the mean is significantly different from the 
OGD+R group, (ANOVA followed by Tukey’s test).
(Fig. 2), we evaluated the ability of PMME extract to counteract 
OGD+R-induced glutamate uptake impairment. OGD+R 
significantly decreased glutamate uptake, and the addition 
of PMME during the re-oxygenation period counteracted this 
OGD+R-induced impairment of glutamate uptake (Figure 4). 
These data suggest that PMME has an inhibitory effect on 
ODG+R –induced glutamate transport impairment, affording 
neuroprotection by inhibiting excitotoxicity.
Adenosine levels rise markedly in response to ischemia, 
hypoxia, excitotoxicity or inflammation, as it is a 
neuroprotectant under these conditions (Lopes et al., 2011). 
In hippocampal glutamatergic nerve terminals, A1 and A2A 
receptors co-localise and functionally interact with a subset 
of these terminals (Rebola et al., 2005); (Ciruela et al., 2006). In 
this study, the neuroprotective effect of PMME was abolished 
in the presence of A1 or A2A adenosine receptor antagonists 
(Figs. 5 and 6), suggesting that A1 and A2A receptors mediate 
the neuroprotective effects of PMME extract in hippocampal slices. 
In contrast, when the antagonists were added to the media during 
the re-oxygenation period (in the absence of PMME extract), they 
did not alter cell death, which indicates that blocking adenosine 
receptors was not detrimental toward hippocampal slices 
compared to OGD+R per se.
Due to their low density in the brain, the possible involvement 
of A3 and A2B receptors in brain function and neuroprotection 
are poorly understood. However, both A3 and A2B are present in 
neural tissue and can be activated under pathological conditions 
(Popoli and Pepponi, 2012). As shown in Figs. 7 and 8, the presence 
of A2B or A3 receptors antagonists (respectively) did not alter the 
PMME-induced increase in cell viability . Therefore, neither the 
A2B nor A3 receptors are involved in the neuroprotective effect of 
PMME against OGD+R in mouse hippocampal slices. Moreover, 
antagonists added to the media during the re-oxygenation period 
Fig. 4 - Effect of PMME on glutamate uptake in hippocampal 
slices subjected to oxygen/glucose deprivation and re-
oxygenation (OGD + R). PMME (5 μg/ml) was added during 
the re-oxygenation period (R). The values are expressed as 
nmol L-[3H] glutamate/mg protein/min and represent the 
means ± SEM of five experiments carried out in triplicate. * 
Indicates that the mean is significantly different from the 
control group (p ≤ 0.01; F = 8.004); # indicates that the mean 
is significantly different from the OGD + R group (p ≤ 0.05;  
F = 8.004) (ANOVA followed by Tukey’s test).
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Fig. 6 - Effect of the adenosine A2A receptor antagonist 
(ZM 241385, 50 nM) on the neuroprotective effect of PMME. 
Control group (dashed lines) was considered to be 100%. The 
values are expressed as the percentage of the control and the 
data represents the mean s± SEM of four experiments carried 
out in triplicate. *** Indicates that the mean is significantly 
different from the control, ZM and OGD + (PMME) R groups,  
p ≤ 0.001; F = 42.05 (ANOVA followed by Tukey’s test).
Fig. 7 - Effect of the adenosine A2B receptor antagonist 
(alloxazine 0,1 μM) on the neuroprotective effect of PMME. 
Control group (dashed lines) was considered to be 100%. The 
values are expressed as the percentage of the control and 
the data represent the means ± SEM of seven experiments 
carried out in triplicate. *** Indicates that the mean is 
significantly different from the control, alox, OGD + (PMME) 
R and OGD + (alox + PMME) R groups, p ≤ 0.001; F = 28.67 
(ANOVA followed by Tukey’s test).
Fig. 8 - Effect of the adenosine A3 receptor antagonist (VUF 
5574, 1 μM) on the neuroprotective effect of PMME. Control 
group (dashed lines) was considered to be 100%. The values 
are expressed as the percentage of the control and the data 
represent the means ± SEM of seven experiments carried 
out in triplicate. *** indicates that the mean is significantly 
different from the control, DMSO, VUF, OGD + (PMME)R and 
OGD+(VUF+PMME)R groups, p ≤ 0.001; F = 10.45 (ANOVA 
followed by Tukey’s test).
Fig. 5 - Effect of the adenosine A1 receptor antagonist (DPCPX, 
100 nM) on the neuroprotective effect of PMME.  The control 
group (dashed lines) was considered to be 100%. The values 
are expressed as the percentage of the control and the data 
represent the means ± SEM of five experiments carried out in 
triplicate. *** indicates that the mean is significantly different 
from the control, DPCPX and OGD + (PMME) R groups, p ≤ 0.001; 
F = 17.64 (ANOVA followed by Tukey’s test).
did not alter cell death, which indicates that blocking adenosine 
receptors was not detrimental toward hippocampal slices 
compared to OGD+R per se.
Taken together, these results indicate that PMME-induced 
neuroprotection involves modulation of the adenosine A1 and 
A2A receptors but not of the A2A or A3 receptors. Presynaptic A2A 
receptors heterodimerise with A1 receptors and tightly regulate 
glutamate release (Ciruela et al., 2006). Thus, we hypothesise 
that PMME extract acts as an agonist of adenosine receptors, 
or it may increase adenosine release into the synaptic cleft, 
which in turn can act on the A1 or A2A receptors and provide 
neuroprotection by decreasing the release of glutamate and 
counteracting neuronal cell death. 
Polyphenols are natural substances with variable phenolic 
structures that are found in vegetables, fruits, grains, bark, roots, 
tea, and wine (Landete, 2012). Dietary phenols are important 
antioxidants (Yang et al., 2009) that are neuroprotective against 
glutamate-induced excitotoxicity (Lee et al., 2003; Martini 
et al., 2007) and ischemia-induced neurodegeneration (Lin, 
2011; Panickar and Jang, 2013; Simonyi et al., 2005). The 
literature demonstrates that extracts containing polyphenols 
(Cho et al., 2010; Gupta et al., 2010; Panickar et al., 2009; Shimada 
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et al., 2000) and isolated polyphenol obtained from Lauraceae 
species provide neuroprotection against OGD-induced cell 
death (Lee et al., 2010) by inhibiting glutamate release (Panickar 
et al., 2012). The Persea genus is rich in polyphenols (Rodriguez-
Carpena et al., 2011) and has demonstrated neuroprotective 
effects against ischemia-induced neuronal death (Eser et al., 2011; 
Yaman et al., 2007). However, to the best of our knowledge, this is 
the first evidence that a species from the Lauraceae family exerts 
neuroprotection against OGD by modulating adenosine receptors.
In conclusion, for the first time, this study demonstrates the 
neuroprotective effect of PMME and its underlying mechanism 
of action in hippocampal brain slices. Few studies have isolated 
and identified the chemical constituents of Persea major. Batista 
et al., (2010) reported the presence of flavonoids, sesquiterpenes 
and lignans. Phytochemical studies are currently in progress 
in our laboratory to elucidate the principles of PMME and its 
relevant mechanism of action. The medical management 
of ischemic stroke is still dependent on thrombolytics, 
anticoagulants and nonspecific neurotonics (Heitsch and 
Panagos, 2013); thus, the introduction of new natural products 
that prevent the effects of glutamate during ischemia opens 
a new chapter for ischemic stroke management that might 
provide substantial benefits for patients.
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